Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/273472 
Year of Publication: 
2023
Series/Report no.: 
ZEW Discussion Papers No. 23-014
Publisher: 
ZEW - Leibniz-Zentrum für Europäische Wirtschaftsforschung, Mannheim
Abstract: 
The COVID-19 pandemic has affected firms in many economies. Exploiting treatment heterogeneity, we use a difference-in-differences design to causally identify the short-run impact of COVID-19 on innovation spending in 2020 and expected innovation spending in subsequent years. Based on a representative sample of German firms, we find that negatively affected firms substantially reduced innovation expenditure not only in the first year of the pandemic (2020) but also in the two subsequent years, indicating 'Long-Covid' effects on innovation. In 2020, innovation expenditure fell by 4.7 % due to the pandemic. In 2022, innovation spending was even 5.4 % lower compared to the counterfactual scenario without the pandemic. Firms with higher pre-treatment digital capabilities show higher innovation resilience during the pandemic. Moreover, COVID-19 leads to a decrease in innovation spending not only in firms that were strongly negatively affected by the pandemic, but also in those firms that experienced a positive demand shock from the pandemic, presumably to increase production capacity.
Subjects: 
COVID-19
innovation
difference-in-differences
economic crisis
resilience
JEL: 
O31
O33
Document Type: 
Working Paper

Files in This Item:
File
Size
749.36 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.